The table below shows Palvella Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
$42.81M
$25.90M
$31.42M
$29.32M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$22.84M
$8.15M
$8.79M
$52.98M
$66.66M
$46.53M
SG&A
$15.76M
PVLA annual revenue (10-K history)
Palvella Therapeutics, Inc. reported annual revenue of $42.81M for fiscal year 2023. That is up 65.3% from $25.90M in fiscal 2022. Over the 10 fiscal years shown, annual revenue grew from $5.37M (FY 2014) to $42.81M. Figures come from the company's audited annual reports as filed with the SEC.